Angela Resch
Physician Assistant · Leavenworth, KSNPI 1598748386
Payments from drug & device makers
Across 624 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$900
- AstraZeneca$737
- Pfizer$713
- Novo Nordisk$654
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$542
- plus $5K from 44 others
What the payments were for
- Food & beverage$10,07399%
- Education$901%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$100
How this compares
$10,163 in reported general payments places this provider in the 95th percentile of 1,016 physician assistant providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 155 | $160,579 |
| EliquisApixaban | 82 | $67,110 |
| TrulicityDulaglutide | 50 | $53,796 |
| MounjaroTirzepatide | 43 | $43,840 |
| JanuviaSitagliptin Phosphate | 34 | $27,734 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $27,493 |
| JardianceEmpagliflozin | 38 | $20,651 |
| Lurasidone Hcl | 20 | $19,902 |
| LinzessLinaclotide | 19 | $19,389 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $17,066 |
| MyrbetriqMirabegron | 19 | $16,841 |
| Nucynta ErTapentadol Hcl | 12 | $11,770 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $10,021 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 66 | $8,192 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 227 | $6,516 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $654 | $160,579155 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $900 | $97,63693 claims |
| PfizerEliquis | $713 | $67,11082 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $225 | $32,01849 claims |
| MerckJanuvia, Dulera | $233 | $31,30345 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $237 | $30,67257 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler | $737 | $25,66463 claims |
| AbbVieLinzess | $1,694 | $19,38919 claims |
| Astellas Pharma US IncMyrbetriq | $394 | $16,84119 claims |
| Collegium Pharmaceutical, Inc.Nucynta Er | $29 | $11,77012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,016 physician assistant providers in Kansas.
Other physician assistant in Leavenworth
- Jarod MarcotteLeavenworth$11K
- Charles GlassLeavenworth$11K
- Sierra FergusonWichita$25K
- Dylan TimmermannTopeka$19K
- Heather HowellKansas City$16K
- Amy BrettmanShawnee$14K
- Ashton YoungersWichita$14K
- Anthony GunawanLakin$13K
- Therese SchrandtWichita$13K
- Mike HallWichita$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.